13F Holdings
中文EN

BICX BioCorRx Inc.

Services-Specialty Outpatient Facilities, NEC · OTC · SEC CIK 1443863 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-78.9%
TTM net income YoY51.3%
TTM EPS YoY52.0%
Revenue 3-yr CAGR-10.2%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-3,921.4%
Net margin-1,837.6%
FCF margin—
EBITDA margin-4,007.3%

Returns

ROE—
ROA-43.8%
ROIC (approx.)—
Asset turnover0.02x

Leverage & solvency

Liabilities / assets826.2%
Debt / equity—
Current ratio0.06x
Interest coverage-30.03x

Cash quality & payout

Operating cash flow / net income0.93x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$797,244$7,665$89,160$213,841$48,272
Cost of revenue—$1,667$35,986$15,279$5,881
Gross profit—$5,998$53,174$198,562$42,391
R&D expense$1.77M$1.48M$891,063$1.46M$1.61M
SG&A expense$3.79M$3.61M$2.88M$3.41M$3.74M
Operating income-$4.83M-$5.12M-$3.79M-$4.70M-$5.51M
Interest expense$223,850$776,780$194,041$150,969$19,424
Pretax income-$3.51M-$5.21M-$3.77M-$4.38M-$5.21M
Income tax$0$0$0$0$0
Net income-$3.44M-$5.11M-$3.77M-$4.38M-$5.21M
EBITDA-$4.79M-$5.09M-$3.76M-$4.67M-$5.45M
EPS (basic)————-0.81
EPS (diluted)-0.19-0.49——-0.81
Weighted avg. shares (diluted)18.49M10.46M2.70M1.45M1.06M
Banking
Net interest income————-$565,684
Noninterest income—$105,978$3,577$7,419$2,384
Balance sheet
Cash & equivalents$139,360$88,033$65,222$68,615$85,838
Receivables$253,459$0$740$35,378—
Inventory$143,425$0———
Current assets$814,468$117,996$187,119$316,910$228,326
PP&E, net$4,062$18,977$50,943$76,572$102,843
Goodwill$563,158$0———
Intangibles$564,460$7,848$9,027$10,206$11,385
Total assets$2.15M$385,941$388,887$766,594$819,975
Current liabilities$8.31M$8.21M$6.43M$5.36M$4.39M
Short-term debt$0——$0$31,580
Long-term debt———$0$99,860
Total debt———$0$131,440
Total liabilities$13.67M$12.74M$10.34M$8.97M$7.78M
Shareholders' equity-$11.22M-$12.12M-$9.82M-$8.08M-$6.96M
Net debt———-$68,615$45,602
Shares outstanding24.49M13.30M8.67M7.72M6.70M
Cash flow statement
Operating cash flow-$2.30M-$1.10M-$1.85M-$2.04M-$3.54M
Capital expenditure———$0$2,017
Free cash flow———-$2.04M-$3.54M
Investing cash flow———$0-$49,997
Financing cash flow$2.35M$1.12M$1.85M$2.02M$3.08M
Depreciation & amortization$44,003$33,145$26,808$27,450$64,328
Stock-based compensation$592,604$1.22M$63,941$354,509$209,515

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.